Purpose: The findings of previous studies have been controversial regarding the optimal surgical procedures required for effective seizure control. In particular, there are varying views as to whether or not lesionectomy of a temporal-lobe-mass lesion is a satisfactory process or whether removal of additional seizure foci is necessary. In this study, we evaluated the efficacy of additional removal of electrically positive foci using intraoperative electrocorticography on mass lesions related to temporal lobe epilepsy. Methods: Thirty-five medically intractable epilepsy patients with temporal-lobe benign mass lesions, who had been surgically treated, were assessed. The relationship between resection of the epilepsy focus using intraoperative electrocorticography and seizure outcome was analyzed. In addition, the sites of residual spikes after lesion removal were evaluated. Results: In this study, the benign mass lesions consisted of 21 gangliogliomas, 8 cavernous angiomas and 6 dysembryoplastic neuroepithelial tumors. The number of 3-year postoperative seizure-free incidences for the group that underwent lesionectomy plus additional spike-positive site resection equated to 90.9%. In contrast, in the group that underwent a lesionectomy only, 76.9% were seizure-free for 3-years postoperatively. After complete removal of mass lesions, 86.4% of the residual spikes were detected over the hippocampus. Conclusion: Even after the complete removal of temporal-lobe-mass lesions, a high frequency of residual spikes was obtained from the hippocampus. Effective surgical seizure control was achieved by carrying out additional procedures on the affected hippocampus. To detect seizure foci surrounding the lesion, especially over the * Corresponding author. Present address:
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Introduction
It has been postulated that postoperative seizure outcome is affected by the 'completeness' of epileptogenic zone resection. The accurate localization of the epileptogenic zone requires careful electroencephalogram (EEG) assessment, including interictal and ictal recordings using a scalp and/or invasive electrode. However, consensus on the electrophysiological approach for mass lesion-related temporal-lobe epilepsy (TLE) has not been established. The importance of carrying out resection of the epileptic area next to the tumor, in terms of seizure outcome, remains controversial.
The effects of a mass lesion on the surrounding brain parenchyma include mechanical compression, increased pressure, ischaemia and specific trophic factors. [1] [2] [3] [4] Particularly in the temporal-lobe region, mass lesions often induce secondary epileptogenicity in the mesiotemporal structures. 5 This indicates that surgical procedures applied to the mesiotemporal structures are a topic of discussion for mass lesion-related TLE cases. Penfield and Jasper recommend that the operative procedure should include removal of the adjacent electrocorticogram (ECoG) active site, in addition to the tumor, to obtain optimal seizure control. 6 Falconer's group carried out a complete temporal lobectomy, including removal of the mesiotemporal structures, resulting in excellent seizure control in 80% of their tumor cases. 7, 8 On the other hand, satisfactory seizure control has also been reported for complete lesionectomies in mass lesion-related TLE patients. 9, 10 In recognition of the generally favorable outcome of lesionectomy only, some physicians have suggested that resection of the surrounding epileptic area may not provide additional seizure control that can be achieved with simple, complete lesionectomy.
To improve seizure outcome, more detailed electrophysiological, histophathological and biochemical knowledge is necessary, and other surgical and/or medical treatments should be examined. In this study, we reviewed temporal-lobe benign mass-lesion-related intractable epilepsy cases, and studied the efficacy of intraoperative ECoG monitoring for surgical results.
Materials and methods
Patients who were surgically treated for medically intractable epilepsy caused by temporal-lobe benign mass lesions at the Department of Neurosurgery of the Tokyo Metropolitan Neurological Hospital from 1989 to 2002 were enrolled in this study. Thirty-five patients were observed for at least 3 years for their seizure outcome. All patients underwent a neurological examination, neuropsychiatry test, magnetic resonance imaging (MRI), computed tomography (CT) and several sessions of scalp EEG with a sphenoidal lead prior to surgery. To determine the seizure semiology, detailed histories were taken from the patients and their relatives, and continuous video or video-EEG monitoring was performed.
Lesionectomies were performed for all temporallobe lesions. Before 1995, it was not possible to perform reliable intraoperative ECoG monitoring. The anesthesia method has now been fine-tuned and we have been able to obtain reliable intraoperative ECoG data since 1995. The first 13 cases were treated by lesionectomy without ECoG monitoring, and were placed in the non-ECoG group. The remaining 22 cases were treated by lesionectomy and additional focus resection based on intraoperative ECoG monitoring, and placed in the ECoG group. The surgeries were carried out by a single neurosurgeon (second author).The approach to mesial temporal-lobe structures was through the superior temporal gyrus corticotomy. The approach to the temporal-lobe tumor, which locates laterally to the mesial temporal-lobe structures, was through the nearest gyrus corticotomy.
Anti-epileptic drugs (AEDs) were discontinued on the morning of surgery. Anesthesia was induced by administering 5.0% sevoflurane and 95.0% oxygen without intravenous narcotic agents, and was maintained using 2.5% sevoflurane with an adequate muscle relaxant. End-tidal CO 2 levels were maintained at around 30 mmHg during ECoG monitoring. The lesionectomy was carried out first, and intraoperative ECoGs were subsequently recorded over the hippocampus, the amygdala, the temporal base area and the lateral surface of the temporal-lobe. Based on the findings of the ECoGs, additional resection was carried out on the adjacent epileptic areas.
The findings of the intraoperative ECoGs and the surgical procedures were reviewed using surgical Surgery for lesional temporal-lobe epilepsy using intraoperative electrocorticographyrecords. The completeness of surgical resection was also reviewed using the records and was confirmed by postoperative MRI. The surgical specimens were examined by hematoxylin-eosin staining and other immunohistochemical staining was carried out if required.
The post-surgical seizure frequency and characteristics, scalp EEGs and MRIs were analyzed 1 and 6 months, aswell as1 year, aftersurgery. Administration of AEDs was decreased when effective seizure control was achieved at the 1-year follow-up stage. Some patients were followed-up at other hospitals, and telephone interviews were therefore performed. The seizure outcomes, level of AED intake and tumor recurrence were further investigated every year for a 3-year postoperative period. To investigate the efficacy of ECoG monitoring for postoperative seizure control, we compared the seizure outcome between the ECoG and non-ECoG groups according to whether they were seizure-free or not, and we subsequently carriedoutstatisticalevaluationbychi-squareanalysis at6months,1year,2yearsand3yearsaftersurgery.APvalue of less than 0.05 was accepted as indicating statistical significance.
For the ECoG group, patients were subdivided based on their tumor locations. Cases with amygdala but not hippocampus involvement composed one group; cases with amygdala and hippocampus involvement were another group; cases with involvement of the hippocampus only were another group; and cases involving the extra-amygdala and hippocampus were the last group. The frequencies of residual spikes after lesionectomy were evaluated for the amygdala, hippocampus, temporal base area and lateral surface of the temporal lobe in each subdivided group.
Neuropsychiatry tests were carried out before and 6 months after the surgery. To investigate their memory function, especially verbal memory function, selective reminding procedures using unrelated words 11 was indicated for the patients who could complete the task. We evaluated the result as a percentage of the reminded number of words. The neuropsychiatry results were compared between the dominant and non-dominant hemisphere surgery and also the ECoG and non-ECoG group.
Results

Clinical characteristics
The clinical characteristics of the ECoG and nonECoG groups are shown in Table 1. The mass lesions   122 H. Sugano et al. Complete tumor resection was confirmed in 31 patients, whereas incomplete resection occurred in three cases of ganglioglioma and in one case of DNTs. Subsequent MRIs showed that tumor recurrence occurred in two patients with ganglioglioma.
The mortality rate was 0%, and the rate of minor postoperative complications relating to surgery was 3.0%, corresponding to 1 case. This patient showed transient motor weakness that was confirmed by the MRI, as being a small cerebral infarction in the basal ganglia.
Seizure outcome
Seizures recurred as the observation period was prolonged; however, the seizure outcomes of both groups did not change 2 years after surgery.
In the ECoG group, the seizure-free occurrences at 6 months, 1, 2 and 3 years postoperatively were 100, 95.5, 90.9 and 90.9%, respectively. In contrast, seizure-free occurrences at the same time points for the non-ECoG group were markedly lower: 92.3, 84.6, 76.9 and 76.9%, respectively. Chi-square analysis to compare seizure-free with non-seizure-free occurrences between the ECoG and non-ECoG groups showed statistical significance after 1 year (P-value = 0.02; Fig. 1 ).
Spike analysis from intraoperative ECoG monitoring
After resecting each lesion, residual spikes were frequently observed over the hippocampus and amygdala. Spikes over the hippocampus were confirmed to occur in 86.4% (19 out of 22) of cases. Even in cases in which the lesions did not involve the hippocampus, residual spikes were frequently observed in 81.8% of cases. The amygdala was the second most frequent region in which residual spikes occurred after lesionectomy, occurring in 63.6% patients, which corresponds to 14 out of 22 cases ( Table 2) .
The frequency of final surgical resection for the hippocampus and amygdala is shown in Table 3 . Although the frequency of hippocampectomy was 20 out of 22 ECoG-recorded cases, 19 cases needed additional resection of the hippocampus according to the intraoperative ECoG findings. This tendency also applied to the amygdala: 14 cases indicated additional resection of the electrically positive residual amygdala.
Neuropsychiatry test
Neuropsychiatry results before and after the surgeries are presented in Fig. 2 . The task was performed in 9 patients in the non-ECoG group and 15 patients in the ECoG group, respectively. The preoperative scores of the verbal memory function Surgery for lesional temporal-lobe epilepsy using intraoperative electrocorticography High frequency residual spikes were observed over the hippocampus (19 out of 22 cases) and amygdala (14 out of 22 cases). Lesions that involved the hippocampus showed spikes over the residual hippocampus in 10 out of 11 cases (91.0%).
were higher in the group that had the lesion located in the non-dominant hemisphere compared with the group that had the lesion located in the dominant hemisphere. Within the non-dominant hemisphere group, post-operative scores improved in four out of five patients in the non-ECoG group and in four out of seven patients in the ECoG group.
On the contrary, the verbal memory function of dominant hemisphere tends to deteriorate after the surgery. This tendency did not differ between the non-ECoG and ECoG groups. Even the cases that had coexisting hippocampal atrophy and that had undergone hippocampal resection worsened the verbal memory function after the surgery. Only 124 H. Sugano et al. Additional resection of the hippocampus and amygdala was carried out in many cases based on intraoperative ECoG. Figure 2 Neuropsychiatry test (selective reminding procedures using unrelated words). Verbal memory functions in both the ECoG and non-ECoG group tends to improve after non-dominant hemisphere surgery. On the contrary, verbal memory functions were worsened after dominant hemisphere surgery in not only the ECoG group but also the non-ECoG group. Circles indicate mesial temporal lobe lesions. Triangles indicate lateral temporal lobe lesions. Dark color indicates cases with coexisting hippocampal atrophy.
the patients that had laterally located lesions in the non-ECoG group maintained the function.
Discussion
Establishing the follow-up period for mass lesionrelated TLE is a significant area that deserves attention. Morris et al. reported that seizure-free occurrences in patients with ganglioglioma decreased as the observation period was prolonged. 12 In our study, seizure-free occurrences also continued to decrease as the follow-up period was prolonged. However, the seizure outcomes of both the ECoG and non-ECoG groups stabilized 2 years after surgery and the ratios were 90.9 and 76.9%, respectively. Consequently, at least 2 years of follow-up is mandatory and the seizure outcome at 2 years postoperatively is meaningful for prediction of future results.
For mass lesion-related intractable epilepsy, one of the surgical goals is the completeness of lesionectomy. Several previous reports noted that complete tumor resection is the most important factor in not only tumor recurrence, but also in seizure control. 4, 5, [13] [14] [15] [16] [17] [18] However, in some reports, despite gross complete resection being accomplished for glio-neural tumors such as gangliogliomas and DNTs, seizure outcomes have been reported as unsatisfactory, and the number of seizure-free occurrences for surgically treated gangliogliomas equates to around 60%. 7, 13, 19 In our study, four patients with ganglioglioma did not cease having seizures, although two patients underwent complete tumor resection. Prayson hypothesized that the cause of unfavorable seizure outcomes for glio-neural tumors may be neuronal migration disorder around the neoplasm. 20, 21 From this hypothesis, the lesionectomy with additional resection of the surrounding cerebral tissue without intraoperative ECoG monitoring seemed to be adequate. The surgical strategy, however, does not show any electrophysiological evidence for any patient. Further basic studies on tumorigenesis and neuronal migration are needed to elucidate the epileptogenic nature of glio-neuronal neoplasms.
Another point of discussion in seizure control is tumor location. Cascino et al. reported that stereotactic lesionectomy is effective for seizure control against mass lesion-related epilepsy, although they also insisted that temporal-lobe lesions are less likely to be rendered seizure-free by using this kind of resection only. 22 Furthermore, some physicians have proposed that mass lesion-related epilepsy in the temporal lobe should be treated in a different way to mass lesion-related epilepsy arising from other locations, and additional resection of mesiotemporal-lobe structures after lesionectomy has improved seizure outcome. 7, 19, [22] [23] [24] [25] [26] [27] On the other hand, other physicians insist that absolute mesiotemporal-lobe resection does not guarantee a better prognosis for mass lesion-related TLE surgery. 5, 28 In this study, lesionectomies only resulted in a 76.9% seizure-free occurrence, but this was further improved to 90.9% by additional resection of the hippocampus and amygdala based on intraoperative ECoG monitoring. As about two-thirds of tumors involved the hippocampus and amygdala, the targets of additional resection were their residual parts. Our results provide evidence that intraoperative ECoG over the hippocampus and amygdala can show the requirement and extent of mesiotemporal-lobe resection in mass lesion-related TLE surgery. Meaningful additional resections of residual mesiotemporal-lobe structures can lead to improved seizure outcome.
From our regional spike analysis, residual spikes from the hippocampus could be detected in 19 out of 22 patients (86.4%) after simple lesionectomy. According to the high frequency of these spikes, we can assume that they could even be detected in non-ECoG group patients in many cases. Despite this, the seizure-free occurrence rate reached an almost acceptable level at 76.9%. In addition, in the non-ECoG group, the lesions were located in extramesial temporal lobes in 5 out of 13 cases, and 4 out of these cases ceased their seizure after complete lesionectomy without resecting the surrounding brain. Therefore, some residual spikes may not influence clinical seizures and the running-down phenomenon may be induced. 29 In such circumstances, these electrophysiological changes presumably do not reach the stage of 'independent secondary epileptogenicity', and effective seizure control may be possible by lesionectomy alone. On the other hand, residual spikes, inducing clinical seizures, certainly exist, as so-called true 'independent secondary epileptogenicity'. Strictly speaking, the treatment of these independent secondary epileptic spikes can improve seizure outcomes. Some characteristic differences among residual spikes must exist; however, it is currently unknown what differences are important for clinical significance. The analysis of spikes from intraoperative ECoG is one method of elucidating this difference.
Additional removal of ECoG-positive sites, particularly the hippocampus and the amygdala, ameliorated the seizure outcome. However, we have to consider the memory function, particularly in cases that have ECoG-positive sites located in the dominant hemisphere. In dominant hemisphere surgery, the postoperative verbal memory function worsened.
This deterioration of cognitive function in dominant hemisphere surgery was seen in both the ECoG and non-ECoG group. Memory function in dominant hemisphere surgery influenced not only the additional removal but also the partial removal of the hippocampus. It is better to define the neurological critical region and seizure origin before the resection, but the current intraoperative ECoG monitoring is not suitable for differentiating such sites because the monitoring is carried out under anesthesia. Other methods to define the spatial and functional differences before the resective surgery, or other surgical procedures to preserve the cognitive function, will be necessary in the future.
Total lesionectomy is required, as noted in previous reports, and additional complete treatment of the epileptic area around the lesion, especially in the hippocampus and amygdala under the guidance of ECoG, is effective for benign mass lesion-related TLE. Cognitive impairment after dominant hemisphere surgery is another future problem that needs to be elucidated.
Conclusions
Even after the complete removal of temporal-lobemass lesions, some spikes remained in the hippocampus with high frequency. Effective surgical seizure control was achieved by carrying out additional procedures on the affected hippocampus. Intraoperative ECoG monitoring over the hippocampus and amygdala is useful for assessing the requirement and extent of mesiotemporal-lobe resection in mass lesion-related TLE surgery.
Cognitive function preservation in the case of dominant hemisphere surgery is another problem. In the future, we need to find other surgical procedures that cease the residual spikes without cognitive impairment.
